We Can Medicines Co., Ltd.
We Can Medicines Co., Ltd. operates a chain of drug stores in Taiwan. The company offers medicine, health food, maternal and baby product, beauty care products, and medical equipment. It sells its products through retail stores and online under the VITALPLUS and Sapporo brands. The company was formerly known as Shenglin Pharmaceutical Co., Ltd. The company was founded in 1972 and is headquartered… Read more
We Can Medicines Co., Ltd. (6929) - Net Assets
Latest net assets as of : NT$- TWD
Based on the latest financial reports, We Can Medicines Co., Ltd. (6929) has net assets worth NT$- TWD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$-) and total liabilities (NT$-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
We Can Medicines Co., Ltd. - Net Assets Trend (None–None)
This chart illustrates how We Can Medicines Co., Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for We Can Medicines Co., Ltd. (None–None)
The table below shows the annual net assets of We Can Medicines Co., Ltd. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to We Can Medicines Co., Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
We Can Medicines Co., Ltd. Competitors by Market Cap
The table below lists competitors of We Can Medicines Co., Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Future Generation Global Ltd
AU:FGG
|
$8.98K |
|
SCIENT DIGIT IMAG
BE:SD0
|
$8.98K |
|
Pengana Private Equity Trust
AU:PE1
|
$8.99K |
|
Wavefront Technology Solutions Inc
PINK:WFTSF
|
$8.99K |
|
Cognetivity Neurosciences Ltd
PINK:CGNSF
|
$8.96K |
|
Fine Besteel Co. Ltd.
KQ:133820
|
$8.95K |
|
BioLASCO Taiwan Co., Ltd.
TWO:6662
|
$8.95K |
|
MATD3F
SA:MATD3F
|
$8.95K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in We Can Medicines Co., Ltd.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares We Can Medicines Co., Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently We Can Medicines Co., Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares We Can Medicines Co., Ltd.'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $17,559,023,800
- Average return on equity (ROE) among peers: 8.12%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| We Can Medicines Co., Ltd. (6929) | NT$- | N/A | N/A | $8.96K |
| Wei Chuan Foods Corp (1201) | $5.55 Billion | 12.34% | 1.69x | $125.16 Million |
| Ve Wong Corp (1203) | $6.25 Billion | 7.16% | 0.53x | $76.18 Million |
| Great Wall Enterprise Co Ltd (1210) | $7.57 Billion | 10.72% | 1.28x | $893.11 Million |
| Charoen Pokphand Enterprise Taiwan Co Ltd (1215) | $5.36 Billion | 14.61% | 0.75x | $839.68 Million |
| Uni-President Enterprises Corp (1216) | $130.79 Billion | 9.49% | 1.59x | $10.01 Billion |
| AGV Products Corp (1217) | $6.27 Billion | 0.76% | 1.01x | $116.99 Million |
| Taisun Enterprise Co Ltd (1218) | $3.67 Billion | 6.42% | 1.09x | $108.34 Million |
| Fwusow Industry Co Ltd (1219) | $3.96 Billion | 5.13% | 1.26x | $99.99 Million |
| Tai Roun Products Co Ltd (1220) | $2.53 Billion | 5.26% | 0.26x | $37.61 Million |
| Formosa Oilseed Processing Co Ltd (1225) | $3.65 Billion | 9.29% | 1.12x | $49.69 Million |